Nov 2023 Newsletter
New Animal Models
Humanized Immune-Checkpoint Mice
Humanized Cytokine Mice
Humanized GPCR Mice
|111864||B-Fcgr1/Fcgrs KO mice|
Humanized Tumor Cell Lines
|322369||B-Tg(WT1 peptide-HLA-A2.1) MC38(service only)|
|322309||B-hVEGFA MC38(service only)|
As the holiday season approaches, we are thrilled to offer you a $1,000 credit that can be applied to your next gene targeting project.
*Limited time only. Must receive PO by December 31, 2023.
Step Inside Our New Facility
Dive into the world of Biocytogen Boston with an exclusive peek into our state-of-the-art space, expanded capacity, and cutting-edge technologies.
Dates: Dec 2-6, 2023
Meet us at Booth 703 and learn more about our custom model generation services and pharmacology services to support your therapeutic discovery and preclinical validation.
Dates: Dec 13-16, 2023
Meet us at Booth 208, and at our 3 posters, to learn more about our antibody discovery platforms, services and other solutions to help support your research projects and pipeline.
Watch our webinar recording on demand: Generation of TCR-mimic antibodies targeting intracellular proteins to expand the druggable target repertoire for anti-tumor therapies